Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Assessing the Effect of Gelesis200 on Body Weight in Overweight and Obese Subjects Without or With Type 2 Diabetes

NCT03058029 is registered in ClinicalTrials.gov with Gelesis, Inc. as lead sponsor.

NCT NCT03058029
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03058029 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Assessing the Effect of Gelesis200 on Body Weight in Overweight and Obese Subjects Without or With Type 2 Diabetes
Lead sponsor
Gelesis, Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
February 22, 2017
Completion date
January 15, 2021
Enrollment
300 (estimated)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, obesity, overweight, prediabetes